BTA-EG4
Modify Date: 2025-08-25 12:52:15
BTA-EG4 structure
|
Common Name | BTA-EG4 | ||
|---|---|---|---|---|
| CAS Number | 921193-28-4 | Molecular Weight | 416.53 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 415.5±47.0 °C at 760 mmHg | |
| Molecular Formula | C22H28N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 205.1±29.3 °C | |
Use of BTA-EG4BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance the neurotoxicity of amyloid peptides in catalase-overexpressing neuronal cells, and can be used in the study of neurodegenerative diseases[1]. |
| Name | BTA-1 |
|---|---|
| Synonym | More Synonyms |
| Description | BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance the neurotoxicity of amyloid peptides in catalase-overexpressing neuronal cells, and can be used in the study of neurodegenerative diseases[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 415.5±47.0 °C at 760 mmHg |
| Molecular Formula | C22H28N2O4S |
| Molecular Weight | 416.53 |
| Flash Point | 205.1±29.3 °C |
| Exact Mass | 240.072113 |
| LogP | 4.07 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.712 |
| 2-(4-Methylaminophenyl)benzothiazole |
| 2-(4'-methylaminophenyl)benzothiazole |
| Benzenamine, 4-(2-benzothiazolyl)-N-methyl- |
| MFCD04974146 |
| 4-(1,3-Benzothiazol-2-yl)-N-methylaniline |
| BTA-1 |